(Reuters) The S&P 500 closed upwards driven by Eli Lilly and Apple, while investors valued the development of United States commercial negotiations with Japan and worried about the prospects for interest rates.
The operators bowed to optimism after the comments of the US president, Donald Trump, about the “great advances” in bilateral conversations after the sharp fall on Wednesday.
Trump also told reporters that he hopes to reach a commercial agreement with China, although he offered no indication of how the two superpowers’ conversations would be launched.
Eli Lilly went up after he said that his experimental pill worked as well as the Ozempic supervent medication to reduce weight and blood sugar in an trial with diabetic patients.
Apple went up, recovering from some of its strong recent losses.
Lee: Trump is confident in achieving a commercial ‘very good agreement’ with China
UnitedHealth collapsed and kept the Dow index in negative terrain, after the insurer lowered her annual gains forecast for the expectations of high medical costs for the rest of the year.
Other health insurance companies also fell, such as CVS Health and human.
According to preliminary data, the S&P 500 won 0.13% to 5,282.01 units, the Nasdaq Composite lost 0.15% to 16,282.90 and the Dow Jones fell 1.33% to 39,140.88 units.
In the week, the S&P 500 dropped 1.57%, the Nasdaq fell 2.62%and the Dow yielded 2.66%.
US actions have been whipped in recent weeks by Trump’s tariffs and their commercial war with China.
The S&P 500 has lost about 6% since April 2, when Trump announced generalized global tariffs that he later paused.
Follow us on Google News to always keep you informed
